Virus-specific T cells (donor-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Virus-specific T cells (donor-derived), covering 2025-03-20 to 2025-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® [Phase 2]